Permanent pacing via implantable defibrillators

PACE - Pacing and Clinical Electrophysiology

Volumn 23, Issue 11 I, 2000, Pages 1667-1682

  Pinski, Sergio L ^a,b   Trohman, Richard G ^a  

^a RUSH MEDICAL COLLEGE   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL HEART PACEMAKER; ASYSTOLE; BRADYCARDIA; DEFIBRILLATOR; ELECTROMAGNETIC FIELD; HEART PACING; HUMAN; REVIEW; TACHYCARDIA;

EID: 0033636819     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2000.01667.x     Document Type: Review

References (105)

1. Long-term multicenter experience with a second-generation implantable pacemaker-defibrillator in patients with malignant ventricular tachyarrhythmias
2. Absence of significant postdefibrillation arrhythmias in patients with automatic implantable defibrillators
3. Sudden bradyarrhythmic death in patients with the implantable cardioverter-defibrillator: Report of two cases
4. Pacemaker syndrome in patients receiving ICDs
5. Advances in dual chamber implantable cardioverter/defibrillators
6. ICD-antiarrhythmic drug and ICD-pacemaker interactions
7. Interactions between transvenous nonthoracotomy cardioverter defibrillator systems and permanent transvenous endocardial pacemakers
8. Preliminary clinical experience with the first dual chamber pacemaker defibrillator
9. Automatic arrhythmia identification using analysis of the atrioventricular association: Application to a new generation of implantable defibrillators
10. A randomized clinical trial of a standardized protocol for the prevention of inappropriate therapy using a dual chamber implantable cardioverter-defibrillator
11. The value of DDD pacing in patients with an implantable cardioverter defibrillator
12. Physiologic cardiac pacing in patients with contemporary implantable cardioverter-defibrillators
13. Indications for implantation of a dual-chamber pacemaker combined with an implantable cardioverter-defibrillator
14. The potential usage of dual chamber pacing in patients with implantable cardioverter-defibrillators
15. Potential benefit of biventricular pacing in patients with congestive heart failure and ventricular tachyarrhythmia
16. Should all candidates for ICD therapy receive a dual-chamber system?
17. Long-term performance of endocardial pacing leads
18. Report of the policy conference of NASPE on device/lead performance and the development of a postmarket surveillance database
19. Clinical presentation of endocardial pacing lead malfunction
20. Sensing-lead related complications in patients with transvenous implantable cardioverter-defibrillators
21. Implantable cardioverter-defibrillator leads: The dark side
22. Sensing lead failure in implantable defibrillators: A comparison of two commonly used leads
23. Poor long term performance of Endotak C-lead in patients with implantable defibrillators
24. Mechanical complications after implantation of multiple-lead nonthoracotomy defibrillator systems: Implications for management and future system design
25. High rate of long-term endovascular lead failure with abdominally placed implantable defibrillators
26. Lead fracture in cephalic versos subclavian approach with transvenous implantable cardioverter-defibrillator systems
27. Cephalic vein guide wire technique for implantation of permanent pacemakers
28. Incidence and implication of abrasion of implantable cardioverter-defibrillator leads
29. Late complications in patients with pectoral defibrillator implants with transvenous defibrillator lead systems: High incidence of insulation breakdown
30. Impedance rise, only clue to severe insulation damage in a transvenous single-lead AICD-system
31. Value of radiography in diagnosing complications of cardioverter-defibrillators implanted without thoracotomy in 437 patients
32. Clinical evaluation of a prototype passive fixation dual chamber single pass lead for dual chamber ICD systems
33. A new single lead electrode for dual chamber ICD systems in the acute human clinical evaluation
34. Estimating defibrillator longevity: A need for an objective comparison
35. Reprogramming pacemakers enhances longevity and is cost-effective
36. Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome
37. Increased pacing threshold after an automatic defibrillator shock in dogs: Effects of class I and class II antiarrhythmic drugs
38. Prospective evaluation of the effect of biphasic waveform defibrillation on ventricular pacing thresholds
39. The effect of biphasic defibrillation on the immediate pacing threshold of a dedicated bipolar, steroid-eluting lead
40. Effect of biphasic endocardial countershock on pacing thresholds in humans
41. The proarrhythmic potential of implantable defibrillators
42. Clinical interactions between pacemakers and automatic implantable cardioverter-defibrillators
43. Comparison of defibrillation efficacy in humans using a new catheter and superior vena cava spring-left ventricular patch electrodes
44. Gross and microscopic pathological changes associated with nonthoracotomy implantable defibrillator leads
45. Pacing threshold increase in nonthoracotomy implantable defibrillator leads: Implications for battery longevity and margin of safety
46. Improved sensing and pacing characteristics utilizing steroid eluting active fixation transvenous defibrillator leads: A randomized trial
47. Considerations for ventricular fibrillation detection by implantable cardioverter defibrillators
48. Internal cardioverter defibrillator device discharge: Experiences of patients and family members
49. Oversensing during ventricular pacing in patients with a third-generation implantable cardioverter-defibrillator
50. Noise detection during bradycardia pacing with a hybrid nonthoracotomy implantable cardioverter-defibrillator system: Incidence and clinical significance
51. Effect of sensing system on the incidence of myopotential oversensing during bradycardia pacing in implantable cardioverter-defibrillators
52. Oversensing of diaphragmatic myopotentials by implantable cardioverter-defibrillators: A unique cause of inappropriate therapy and inhibition of pacing
53. Myopotential sensing by a dual chamber implantable cardioverter-defibrillator: Two case reports
54. Inappropriate shocks from implanted cardioverter defibrillators caused by sensing of diaphragmatic myopotentials
55. Inappropriate shocks delivered by implantable cardioverter-defibrillators during oversensing of activity of diaphragmatic muscle
56. Spontaneous and provoked diaphragmatic myopotential oversensing in patients with ICDs: Incidence and relationship to clinical variables, sensing lead configuration and sensing algorithms
57. Alternative lead positioning in the right ventricular outflow tract in transvenous implantation of ICDs
58. Permanent right ventricular outflow septal placement of active-fixation pacing-defibrillation leads: Safety and efficacy for pacing and defibrillation
59. Sensing and tachyarrhythmia detection problems in implantable cardioverter defibrillators
60. Inappropriate pacing due to autoperpetuation of the ventricular rate stabilization algorithm: A manifestation of T-wave oversensing by ICDs
61. Comparison of oversensing during bradycardia pacing in two types of implantable cardioverter-defibrillator systems
62. Problems in managing patients with long QT syndrome and implantable cardioverter-defibrillators: A report of two cases
63. QT dependent T wave sensing
64. Inappropriate pauses during bradycardia pacing in a third-generation implantable cardioverter defibrillator
65. Inhibition of bradycardia pacing caused by far-field atrial sensing in a third-generation cardioverter defibrillator with an automatic gain feature
66. Inappropriate discharges of an implantable cardioverter defibrillator secondary to automatic adjustable gain of atrial tachycardia
67. Inappropriate discharge of an implantable cardioverter-defibrillator during atrial flutter and intermittent ventricular antibradycardia pacing
68. Interference with cardiac pacing
69. Interference with an implantable defibrillator by an electronic antitheft-surveillance device
70. Study of pacemaker and implantable cardioverter-defibrillator triggering by electronic article surveillance devices (SPICED TEAS)
71. Interactions between electronic article surveillance systems and implantable cardioverter-defibrillators
72. Digital cellular telephone interaction with implantable cardioverter-defibrillators
73. Cellular phone interference testing of implantable cardiac defibrillators in vitro
74. Ausencia de interferencia entre telefonos moviles GSM y desfibriladores implantables: Estudio in vivo
75. Comparison of single- and dual-coil active pectoral defibrillation lead systems
76. Measurement of ventricular electrogram amplitude during intraoperative induction of ventricular tachyarrhythmias
77. Adequacy of implantable cardioverter-defibrillator lead placement of tachyarrhythmia detection by sinus rhythm electrogram amplitude
78. Reproducibility of ventricular fibrillation characteristics in patients undergoing implantable cardioverter-defibrillator implantation
79. The relationship between induced and spontaneous ventricular fibrillation
80. Ventricular fibrillation and competitive pacing
81. Initiation of ventricular tachycardia: Analysis of intracardiac electrograms in patients with internal cardioverter defibrillator
82. Effect of rate and coupling interval on endocardial R wave amplitude variability in permanent ventricular sensing lead systems
83. Dual level sensing significantly improves automatic threshold control for R wave sensing in implantable defibrillators
84. Paced beats following single nonsensed complexes in a 'codependent' cardioverter defibrillator and bradycardia pacing system: Potential for ventricular tachycardia induction
85. Ventricular pacing induced ventricular tachycardia in patients with implantable cardioverter-defibrillators
86. Pacing induced ventricular fibrillation in internal cardioverter defibrillator patients: A new form of proarrhythmia
87. Spontaneous sequences of onset of torsades de pointes in patients with acquired prolonged repolarization: Quantitative analysis of Holter recordings
88. Analysis of the initiation of spontaneous monomorphic ventricular tachycardia by stored intracardiac electrograms
89. Prevention of torsade de pointes in the congenital long QT syndrome: Use of a pause prevention pacing algorithm
90. Importance of abortive shock capability with electrogram storage in cardioverter-defibrillator devices
91. Inappropriate shock therapy for nonsustained ventricular tachycardia in a dual chamber pacemaker defibrillator
92. Adverse events with dual-chamber implantable cardioverter-defibrillators
93. Usefulness of a dynamic postpace ventricular blanking period in dual-chamber, rate-responsive implantable defibrillators
94. A prospective randomized-controlled trial of ventricular fibrillation detection time in a DDDR ventricular defibrillator
95. Dual chamber pacemaker defibrillators: A unique form of crosstalk inhibition
96. Software error resulting in malfunction of an implantable cardioverter-defibrillator